Discontinued — last reported Q2 '25
Medline, Inc. Convertible Debt - Current increased by 0.5% to $368.00M in Q1 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels of current convertible debt increase liquidity pressure and potential dilution risk for existing shareholders.
This represents the portion of debt instruments that can be converted into equity and are due for repayment or conversio...
Common in high-growth technology firms; peers often use this to manage interest costs while providing equity upside to investors.
convertible_debt_current| Q4 '24 | Q1 '25 | |
|---|---|---|
| Value | $366.00M | $368.00M |
| QoQ Change | — | +0.5% |